scholarly article | Q13442814 |
P356 | DOI | 10.1161/01.ATV.11.6.1667 |
P698 | PubMed publication ID | 1931869 |
P2093 | author name string | M Wong | |
J H Rapp | |||
R J Stoney | |||
G S Herron | |||
E Unemori | |||
M H Hibbs | |||
P433 | issue | 6 | |
P921 | main subject | connective tissue | Q25615 |
P304 | page(s) | 1667-1677 | |
P577 | publication date | 1991-11-01 | |
P1433 | published in | Arteriosclerosis and thrombosis : a journal of vascular biology | Q27709770 |
P1476 | title | Connective tissue proteinases and inhibitors in abdominal aortic aneurysms. Involvement of the vasa vasorum in the pathogenesis of aortic aneurysms | |
P478 | volume | 11 |
Q81706496 | Abdominal aortic aneurysm |
Q72390494 | Abnormal expression of plasminogen activators in aortic aneurysmal and occlusive disease |
Q71218618 | Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms |
Q37452257 | An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. |
Q52889768 | Angiogenesis in abdominal aortic aneurysms. |
Q35746906 | Angiotensin II increases urokinase-type plasminogen activator expression and induces aneurysm in the abdominal aorta of apolipoprotein E-deficient mice |
Q34950585 | Binding sites for ETS family of transcription factors dominate the promoter regions of differentially expressed genes in abdominal aortic aneurysms |
Q35093966 | Cancer cell invasion: treatment and monitoring opportunities in nanomedicine. |
Q72758247 | Captopril inhibits the 72 kDa and 92 kDa matrix metalloproteinases |
Q71657591 | Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall |
Q57460608 | Contrast-enhanced ultrasound of the abdominal aorta - current status and future perspectives |
Q35763570 | Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. |
Q71093820 | Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase |
Q80376892 | Effects of calcium channel blocker azelnidipine on experimental abdominal aortic aneurysms |
Q73515993 | Elastin degradation products induce adventitial angiogenesis in the Anidjar/Dobrin rat aneurysm model |
Q36820325 | Elastin-elastases and inflamm-aging |
Q73113708 | Enhanced embryonic nonmuscle myosin heavy chain isoform and matrix metalloproteinase expression in aortic abdominal aneurysm with rapid progression |
Q35749972 | Expression and Cellular Localization of 15-Hydroxy-Prostaglandin-Dehydrogenase in Abdominal Aortic Aneurysm |
Q24564318 | Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms |
Q73676314 | Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta |
Q92627712 | Hair whitening and obesity are independently related to ascending aorta dilatation in young-middle aged men |
Q35437393 | Heat shock protein 90 inhibition by 17-DMAG attenuates abdominal aortic aneurysm formation in mice |
Q72057993 | In situ localization and quantification of seventy-two – kilodalton type IV collagenase in aneurysmal, occlusive, and normal aorta |
Q44734355 | Increased MMP-9 expression and activity by aortic smooth muscle cells after nitric oxide synthase inhibition is associated with increased nuclear factor-kappaB and activator protein-1 activity |
Q77773046 | Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms |
Q71218656 | Increased synthesis of matrix metalloproteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms |
Q28374933 | Indomethacin inhibits expansion of experimental aortic aneurysms via inhibition of the cox2 isoform of cyclooxygenase |
Q35747748 | Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms |
Q52536505 | Long-term alcohol consumption increases matrix metalloproteinase-2 activity in rat aorta. |
Q47963564 | Matrix Metalloproteinase Expressions in Arteriosclerotic Aneurysmal Disease |
Q59384974 | Matrix metalloproteinases can facilitate the heparanase-induced promotion of phenotypic change in vascular smooth muscle cells |
Q52507754 | Medial neovascularization in abdominal aortic aneurysms: a histopathologic marker of aneurysmal degeneration with pathophysiologic implications. |
Q37305427 | Microvascular COX-2/mPGES-1/EP-4 axis in human abdominal aortic aneurysm. |
Q28537641 | Notch γ-secretase inhibitor dibenzazepine attenuates angiotensin II-induced abdominal aortic aneurysm in ApoE knockout mice by multiple mechanisms |
Q38009305 | Novel cardiac-specific biomarkers and the cardiovascular continuum |
Q41288569 | Pathogenesis of abdominal aortic aneurysms--cellular and biochemical mechanisms |
Q36688605 | Pathology, natural history and treatment of abdominal aortic aneurysms |
Q73422910 | Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms |
Q35750610 | Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages |
Q73341698 | Prostaglandin E2 synthesis and cyclooxygenase expression in abdominal aortic aneurysms |
Q26798395 | Recent Advances in the Development of Experimental Animal Models Mimicking Human Aortic Aneurysms |
Q35584927 | Regulation of matrix metalloproteinases: an overview |
Q41771655 | Relationship between Serum Gamma-glutamyl Transferase Levels with Ascending Aortic Dilatation |
Q41815321 | Simvastatin inhibits angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-knockout mice: possible role of ERK |
Q74598066 | Source of elastin-degrading enzymes in mycotic aortic aneurysms: bacteria or host inflammatory response? |
Q52534168 | Suppression of experimental abdominal aortic aneurysms by systemic treatment with a hydroxamate-based matrix metalloproteinase inhibitor (RS 132908). |
Q85198879 | Uric Acid as a Marker of Oxidative Stress in Dilatation of the Ascending Aorta |
Search more.